NFKB1 and COVID-19: Until now, although a lot of studies have shown that NF-κB-mediated inflammatory dysfunction induced by SARS-CoV-2 contributed to worse prognosis and higher mortality of COVID-19 patients with hypertension, the underlying mechanism was still unclear.